Investors seeking to buy high-yield dividend stocks need to know where to look.
With market conditions mimicking pre-recession – an inverted yield curve, debts, and late payments on the rise – profiting from dividends looks more and more like striking gold.
Investors are always seeking the secret weapon to help them achieve life-changing gains.
You can search forever for new strategies, but the truth the best system to find these types of gains is right in front of you.
by Tom Gentile
The financial news networks have their hands full.
That's why today, I want to talk to you about something they're missing…
You see, the buyback corner of the market has been serving up record-breaking numbers lately.
Now, I know that "buybacks" may not sound like the most exciting thing in the news right now – but the truth is, they're extremely important for the overall market.
And this could be the one catalyst we're looking for to rally the market higher.
Eager investors are hoping the Lyft IPO will be their next opportunity for market-beating gains this year.
Unfortunately, you won't be able to invest in Lyft stock right now because the IPO hasn't happened yet.
But that doesn't mean there isn't a way to profit off the most exciting companies on the market...
By 2025, the biotech industry will be worth will be $727 billion – a 120% increase over its total value in 2015.
To help you take advantage of the tremendous gains in biotech stocks, we're bringing you the three best biotech stocks to buy this month.
Stocks have been flat this year, but that doesn't mean sharp traders aren't making money hand over fist. After all, we're still in the middle of the second-longest bull market ever.
And you can be one those traders raking in money while other investors languish with index funds…
Since hitting a high in late January, the iShares Nasdaq Biotechnology ETF has slumped more than 11%. But that doesn't mean investors should stop looking for the best biotech stocks to buy today.
You see, the slump in biotech stocks has little to do with their true worth.
In fact, some of the best biotech stocks are currently trading well below their fundamental value, according to their earnings and assets.
Here are the three best biotech stocks to buy now, while they're still on sale...
by Stephen Mack
AbbVie Inc., a biotech stock we like, took a hit last week following disappointing mid-phase trial results for one of its pipeline drugs.
We see no reason to change our recommendation: This stock is still poised for long-term growth.
Find out why Wall Street's overreaction could be your gain...
by Stephen Mack
We start off our latest list of best stocks to buy now with two smart plays on cryptocurrencies and blockchain technology.
Plus, we've got a great play on the coming silver bull, one of the most reputable banks in the country, and a dividend warrior.
Don't miss these opportunities.
After the last few weeks of violent market swings – way up one day, way down the next – you might feel like there are no new moves you can make.
While it can seem a bit scary out there, that's not true.
When volatility hits, as it has since late January, one smart move you can make is to start buying companies that richly reward their investors through dividends and stock buybacks. These are companies that are going to pay off no matter the noise in the markets.
"But!" – I can hear you folks crying – "dividend stocks are boring." You're looking for fast-growing Silicon Valley startups and companies in frontier fields like biotech… legal marijuana… and the blockchain and cryptocurrencies.
As a growth-centric investor, I too used to think of dividend payers as firms that have lost their cutting-edge fervor.
Well, that was then. This is now...
